Clinical Trial: The Impact of Prophylactic Antibacterial Agent Administration on the Prognosis of Patients with Liver Cirrhosis Complicated by Upper Gastrointestinal Bleeding (China)

Posted On: 2026-11-02

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Impact of Prophylactic Antibacterial Agent Administration on the Prognosis of Patients with Liver Cirrhosis Complicated by Upper Gastrointestinal Bleeding'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135647

Registration Time: 2026/10/31

Type: Observational study

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322565

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The Impact of Prophylactic Antibacterial Agent Administration on the Prognosis of Patients with Liver Cirrhosis Complicated by Upper Gastrointestinal Bleeding (China)